Crossmark

Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Crossref DOI link: https://doi.org/10.1186/s41120-023-00072-x

Published Online: 2023-04-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Needham, David https://orcid.org/0000-0002-0082-9148
License Information

Text and Data Mining valid from 2023-04-14

Version of Record valid from 2023-04-14
More Information

Article History

Received: 29 October 2022

Accepted: 9 January 2023

First Online: 14 April 2023

Declarations

:

: Duke University has assigned the rights for the provisional patent applications to David Needham and his entity, Needham Material Science LLC.

Document is current

Any future updates will be listed below